Evolent Health(EVH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EVH Evolent Health

Market Closed 09-18 16:00:00 EDT

3.69

+0.02

+0.54%

盘后3.68

-0.01-0.27%

19:30 EDT

High3.73	Low3.63	Vol2.56M
Open3.65	D1 Closing3.67	Amplitude2.72%
Mkt Cap417.19M	Tradable Cap347.41M	Total Shares113.06M
T/O9.43M	T/O Rate2.72%	Tradable Shares94.15M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EVH","market":"US","secType":"STK","nameCN":"Evolent Health","latestPrice":3.69,"timestamp":1789761600000,"preClose":3.67,"halted":0,"volume":2563716,"hourTrading":{"tag":"盘后","latestPrice":3.6801,"preClose":3.69,"latestTime":"19:30 EDT","volume":184005,"amount":678888.2754,"timestamp":1789774206930,"change":-0.0099,"changeRate":-0.002683,"amplitude":0.002683},"delay":0,"changeRate":0.005449591280653956,"floatShares":94148000,"shares":113059335,"eps":-4.541901,"marketStatus":"Market Closed","change":0.02,"latestTime":"09-18 16:00:00 EDT","open":3.65,"high":3.725,"low":3.625,"amount":9433133.2874172,"amplitude":0.027248,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.541901,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1433476800000,"exchange":"NYSE","adjPreClose":3.67,"postHourTrading":{"tag":"盘后","latestPrice":3.6801,"preClose":3.69,"latestTime":"19:30 EDT","volume":184005,"amount":678888.2754,"timestamp":1789774206930,"change":-0.0099,"changeRate":-0.002683,"amplitude":0.002683},"volumeRatio":0.795980412522332,"impliedVol":0.2381,"impliedVolPercentile":0.0359},"requestUrl":"/m/hq/s/EVH","defaultTab":"news","newsList":[{"id":"2663901324","title":"Evolent Health President Daniel Joseph McCarthy Sells 65,892 Shares for $329,460","url":"https://stock-news.laohu8.com/highlight/detail?id=2663901324","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663901324?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:19","pubTimestamp":1787948345,"startTime":"0","endTime":"0","summary":"Evolent Health President Daniel Joseph McCarthy sells 65,892 shares for $329,460Evolent Health President Daniel Joseph McCarthy sold 65,892 Class A common shares on Aug. 26, 2026 at $5.Direct holdings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL7p62t4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Evolent Health President Daniel Joseph McCarthy Sells 65,892 Shares for $329,460","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","EVH","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660928659","title":"Humana Names Shantanu Nundy Chief Medical Officer Effective Aug. 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2660928659","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660928659?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:01","pubTimestamp":1787223661,"startTime":"0","endTime":"0","summary":"Humana names Shantanu Nundy chief medical officer effective Aug. 31Humana named Shantanu Nundy as chief medical officer, effective Aug. 31.Nundy joins from Accolade, where he was executive vice presid","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL1G0xWz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","LU0170899867.USD","LU1983260115.SGD","LU0238689110.USD","IHF","SG9999014005.SGD","BK4533","LU0070302665.USD","BK4588","LU1093756325.SGD","LU1093756168.USD","LU0208291251.USD","LU0348723411.USD","SG9999014013.SGD","FXH","BK4566","BK4154","LU0417517546.SGD","LU0211331839.USD","BK4167","LU0266013472.USD","EVH","HUM","LU0256863811.USD","BK4585","LU0320765489.SGD","LU0390134368.USD","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659860904","title":"Evolent Health Price Target Cut to $6.00/Share from $7.00 by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2659860904","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659860904?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:36","pubTimestamp":1786556160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EVH/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658297974","title":"Truist Financial Sticks to Their Hold Rating for Evolent Health (EVH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658297974","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658297974?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:36","pubTimestamp":1786534580,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Jailendra Singh maintained a Hold rating on Evolent Health today and set a price target of $6.00. Singh covers the Healthc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-their-hold-rating-for-evolent-health-evh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-their-hold-rating-for-evolent-health-evh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658191703","title":"Evolent Health Shares Rise After Citigroup Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2658191703","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658191703?lang=en_us&edition=fundamental","pubTime":"2026-08-12 02:36","pubTimestamp":1786473374,"startTime":"0","endTime":"0","summary":"Evolent Health (EVH) shares rose 3% in Tuesday trading after Citigroup upgraded the stock to buy from neutral and adjusted its price target to $6 from $6.75.Trading volume stood at 2.6 million shares, compared with a daily average of 3 million.Price: 4.05, Change: +0.12, Percent Change: +3.05","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658583997","title":"Citigroup Upgrades Evolent Health to Buy From Neutral, Adjusts PT to $6 From $6.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2658583997","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658583997?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:37","pubTimestamp":1786448229,"startTime":"0","endTime":"0","summary":"Evolent Health (EVH) has an average rating of buy and mean price target of $5.96, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658493697","title":"Evolent Health Price Target Cut to $6.00/Share from $7.00 by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2658493697","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658493697?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:18","pubTimestamp":1786364280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EVH/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658989344","title":"Analysts Conflicted on These Healthcare Names: Evolent Health (EVH), Eli Lilly & Co (LLY) and BioMarin Pharmaceutical (BMRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658989344","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658989344?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:00","pubTimestamp":1786348852,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Evolent Health (EVH), Eli Lilly & Co (LLY) and BioMarin Pharmaceu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-evolent-health-evh-eli-lilly-co-lly-and-biomarin-pharmaceutical-bmrn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-evolent-health-evh-eli-lilly-co-lly-and-biomarin-pharmaceutical-bmrn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGXZ57979304.SGD","CANC","LU0354030438.USD","LU2168564495.EUR","LU2552382058.USD","LU0266013472.USD","LU0353189763.USD","LU1069344957.HKD","LU0289739699.SGD","LU1712237335.SGD","LU0820561818.USD","LU0198837287.USD","LU2063271972.USD","MHIP","LU2237443622.USD","LU0158827781.USD","LU2237438978.USD","LU2237443382.USD","LU2417539215.USD","LU2471134879.HKD","BK4599","LU1551013342.USD","IE00BJJMRX11.SGD","SGXZ31699556.SGD","LU0683600562.USD","IE00BFTCPJ56.SGD","LU1804176565.USD","LU2168563687.JPY","LU0823416689.USD","LU2750360997.AUD","LU0786609619.USD","LU2237443549.SGD","LU0096364046.USD","BMRN","LU1064131342.USD","LU0058720904.USD","LU0354030511.USD","LU2602419157.SGD","LU2471134952.CNY","LU2361044949.HKD","SG9999014898.SGD","TMED","LU0820562030.AUD","LU1979441026.SGD","LLII","THNR","LU1720051108.HKD","IE00BFSS7M15.SGD","LU0061475181.USD","LU2361045086.USD","IE00B7KXQ091.USD","JDOC","BK4167","LU1280957306.USD","LU2491049909.HKD","SG9999001176.SGD","LU0320765059.SGD","LU2896262040.SGD","LU0256863902.USD","LU2462157665.USD","LU1127390331.HKD","LU0689472784.USD","LU0640476718.USD","IE00BKDWB100.SGD","LU0203201768.USD","LU1145028129.USD","BK4533","GB00BDT5M118.USD","IE0001KFT4U8.USD","LLYZ","LU0053671581.USD","LU0820561909.HKD","FTXH","LU0672654240.SGD","SG9999014906.USD","SG9999015945.SGD","SGXZ99366536.SGD","BK4007","LU0471298694.HKD","LU0385154629.USD","LLY","LU1868836914.USD","IE0009355771.USD","LU0158827948.USD","IE00B775H168.HKD","ELIS","LU2746668461.USD","LU1814569148.SGD","LU2023251221.USD","OZEM","AGNG","LU0432979614.USD","LU2108987350.USD","IE0004445015.USD","LU0964807845.USD","LU1988902786.USD","LU1720051017.SGD","LU2746668974.SGD","LU2265009873.SGD","LU2089984988.USD","IE00B7SZLL34.SGD","LU1551013425.SGD","IYH","LU1868836757.USD","LU0079474960.USD","LU0823434583.USD","LU0353189680.USD","LU0471298777.SGD","LU2237443895.HKD","LU0256863811.USD","SG9999018865.SGD","LU1974910355.USD","LU2087625088.SGD","LU0456855351.SGD","LU0708995401.HKD","LU1291159041.SGD","LU0787776722.HKD","LU2237443465.HKD","IE00BK4W5L77.USD","LU2461242641.AUD","LU1035775433.USD","IHE","IE00B1BXHZ80.USD","BK4581","VHT","LU2271345857.HKD","SG9999018857.SGD","LU1023059063.AUD","LU2211815571.USD","IE00BN29S564.USD","LU2089284900.SGD","LU0238689110.USD","IE00BFSS8Q28.SGD","LU0106261372.USD","LLYX","LU2491050154.USD","LU1623119135.USD","SG9999001176.USD","LU1366192091.USD","LU1868837300.USD","LU0109394709.USD","SG9999014914.USD","LU1232071149.USD","SG9999014880.SGD","LU0417517546.SGD","LU0097036916.USD","LU0006306889.USD","LU1868837136.USD","LU2750360641.GBP","LU0323591593.USD","RXL","IE0002141913.USD","IE0002270589.USD","LU0109391861.USD","LU1868836591.USD","LU2168564065.EUR","SG9999017495.SGD","IE00B4R5TH58.HKD","LU2168564149.EUR","LU2264538146.SGD","LU2491050071.SGD","LU0345770993.USD","LU1093756325.SGD","LU2471134523.USD","LU2089283258.USD","IE0004445239.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU1548497426.USD","LU0094547139.USD","IXJ","FHLC","LU0882574055.USD","LU2552382132.HKD","IE00BK4W5M84.HKD","LU0823434740.USD","LU1267930730.SGD","LU1093756168.USD","BK4566","LU0203202063.USD","BK4534","IE00BKPKM429.USD","LU0882574139.USD","LU1983299246.USD","LU1057294990.SGD","IE00BWXC8680.SGD","LU0234572021.USD","LU1629891620.HKD","LU0210536198.USD","LU0889565916.HKD","BK4516","EVH","IE00B19Z3B42.SGD","LU2357305700.SGD","LU1917777945.USD","SG9999015978.USD","SGXZ51526630.SGD","CURE","LU0122379950.USD","SG9999013999.USD","LU1323610961.USD","LU0133085943.USD","SG9999015952.SGD","LU2471134796.USD","LU2023250330.USD","LU0943347566.SGD","LU0174119429.USD","LU2236285917.USD","SGXZ81514606.USD","HRTS","IE00B19Z3581.USD","LU2360106947.USD","WDNA","BK4588","LU2023250504.SGD","LU2468319806.SGD","MEDX","IE00B2B36J28.USD","LU2756315318.SGD","TRUH","LU2756315664.SGD","ELIL","IE0005OL40V9.USD","IE00BJLML261.HKD","LU0345770308.USD","GDOC","LU2111349929.HKD","LU2168564222.USD","BK4585","IE00B1XK9C88.USD","LU0114720955.EUR","LU0320765992.SGD","LU2213496289.HKD","IE00BJJMRZ35.SGD","LU0466842654.USD","LU2462591350.SGD","ILDR","SG9999015986.USD","MEDI","LU2237443978.SGD","LU1989771016.USD","LU2028103732.USD","LU2324357040.USD","LU0225283273.USD","LU2552382215.SGD","LU0316494557.USD","LU2106854487.HKD","PJP","LU1061106388.HKD","IE00BJJMRY28.SGD","LU2361044865.SGD","IE00B4JS1V06.HKD","LU2456880835.USD","PPH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658605209","title":"Evolent Health Earnings Call Balances Growth and Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2658605209","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658605209?lang=en_us&edition=fundamental","pubTime":"2026-08-10 08:21","pubTimestamp":1786321270,"startTime":"0","endTime":"0","summary":"Evolent Health Inc. (($EVH)) has held its Q2 earnings call. Read on for the main highlights of the call. Evolent Health’s latest earnings call stru...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evolent-health-earnings-call-balances-growth-and-risk-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evolent-health-earnings-call-balances-growth-and-risk-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657622862","title":"Evolent Health (EVH) Stock Rebounds As Growth Momentum Confronts Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2657622862","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657622862?lang=en_us&edition=fundamental","pubTime":"2026-08-08 08:25","pubTimestamp":1786148759,"startTime":"0","endTime":"0","summary":"Evolent Health stock jumped 10% to US$3.95 after its Q2 report, a sharp move for a company that has been weak over the past month and choppy over the past quarter. The headline is clear. Revenue reached US$652.5m in Q2 while the company still reported a net loss, and yet investors focused on the growth story and updated outlook.\nThe bigger story now sits beyond today’s bounce. Management is talking about multi year revenue expansion, persistent losses and a valuation that screens low on...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-evh/evolent-health/news/evolent-health-evh-stock-rebounds-as-growth-momentum-confron","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-evh/evolent-health/news/evolent-health-evh-stock-rebounds-as-growth-momentum-confron","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0053671581.USD","EVH","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657366133","title":"Evolent Health: Buy Rating Reiterated as Strong Contracts and Enhanced Risk Protections Support Growth; $5 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2657366133","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657366133?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:35","pubTimestamp":1786055740,"startTime":"0","endTime":"0","summary":"In a report released today, Matthew Shea from Needham reiterated a Buy rating on Evolent Health, with a price target of $5.00. Matthew Shea has giv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/evolent-health-buy-rating-reiterated-as-strong-contracts-and-enhanced-risk-protections-support-growth-5-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/evolent-health-buy-rating-reiterated-as-strong-contracts-and-enhanced-risk-protections-support-growth-5-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657925668","title":"Progyny Q2 Revenue Rises 5%, Slightly Beats Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657925668","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657925668?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:31","pubTimestamp":1786048265,"startTime":"0","endTime":"0","summary":"Progyny Q2 revenue rises 5%, slightly beats estimatesOverviewWomen's health benefits provider's Q2 revenue rose 5%, slightly beating analyst expectationsQ2 adjusted EBITDA rose 7%, beating analyst exp","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431EL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0053671581.USD","PRVA","HNGE","BK4154","LU1878469433.USD","BK4196","EVH","BK4539","PGNY","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657246659","title":"Evolent Health: Improving Fundamentals, Raised Long‑Term Guidance and Strong Contract Pipeline Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2657246659","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657246659?lang=en_us&edition=fundamental","pubTime":"2026-08-07 01:35","pubTimestamp":1786037749,"startTime":"0","endTime":"0","summary":"William Blair analyst Ryan Daniels has reiterated their bullish stance on EVH stock, giving a Buy rating on July 28. Ryan Daniels has given his Buy...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/evolent-health-improving-fundamentals-raised-longterm-guidance-and-strong-contract-pipeline-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/evolent-health-improving-fundamentals-raised-longterm-guidance-and-strong-contract-pipeline-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657630548","title":"Evolent Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657630548","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657630548?lang=en_us&edition=fundamental","pubTime":"2026-08-06 22:16","pubTimestamp":1786025791,"startTime":"0","endTime":"0","summary":"Evolent Health, Inc. reports results for the quarter ended June 30 - Earnings SummaryEvolent Health, Inc.EVH.Nreported quarterly adjusted earnings of 2 cents per share for the quarter ended June 30, h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N44328L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVH","LU0053671581.USD","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657335556","title":"Evolent Q2 2026 Earnings: Revenue Growth Came With Margin Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2657335556","media":"TradingKey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657335556?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:17","pubTimestamp":1786015060,"startTime":"0","endTime":"0","summary":"Evolent Health’s (NYSE: EVH) Q2 2026 revenue rose 46.9% year over year to $652.5 million, while its GAAP diluted loss narrowed to $0.25 per share from $0.44. Performance Suite revenue increased 80.8%, but profitability weakened as the medical expense ratio climbed to 95.3% and adjusted EBITDA fell 25.3% to $28.1 million. Evolent raised full-year revenue guidance to $2.6 billion-$2.7 billion, tightened adjusted EBITDA guidance to $120 million-$135 million, and outlined a 2027 outlook supported by scheduled launches and oncology demand.","market":"nz","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock11.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock11.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/earnings/262082979-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","LU0053671581.USD","EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657163638","title":"Evolent Q2 FY26 Net Loss Narrows to $28.36 Million; Revenue Rises 46.84% to $652.52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657163638","media":"Reuters","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657163638?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:07","pubTimestamp":1786014473,"startTime":"0","endTime":"0","summary":"Evolent Q2 FY26 net loss narrows to $28.36 million; revenue rises 46.84% to $652.52 millionEvolent Health posted Q2 2026 revenue of USD 652.52 million, up 46.85% from a year earlier; net loss narrowed","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL6cNqGX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","LU0053671581.USD","EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657684638","title":"Evolent Health Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $652.520M Beat $597.997M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657684638","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657684638?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:05","pubTimestamp":1786014310,"startTime":"0","endTime":"0","summary":"Evolent Health (NYSE:EVH) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.02) by 200 percent. This is a 120 percent increase over losses of $(0.10) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60987410/evolent-health-q2-adj-eps-0-02-beats-0-02-estimate-sales-652-520m-beat-597-997m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657388156","title":"Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657388156","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657388156?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:01","pubTimestamp":1786014066,"startTime":"0","endTime":"0","summary":"BRIEF-Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 MillionAug 06 (Reuters) - Evolent Health Q2 adjusted EBITDA USD 28.05 million.Q2 adjusted EBITDA margin 4.3%Q2 net income USD -28.364 millionoutlook FY adjusted EBITDA USD 120-135 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXDH2JT5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVH","LU0053671581.USD","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638068","title":"Evolent Health, - Raises 2026 Revenue Guidance to $2.6-$2.70 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638068","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638068?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXDH2JT5:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","EVH","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638053","title":"Evolent Health, - Expects 2027 Revenue Growth over 25% Compared to 2026 and Adj Ebitda Midpoint at or Above $150 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638053","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638053?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014006,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXDH2JT5:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","EVH","BK4167"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evolent.com","stockEarnings":[{"period":"1week","weight":-0.1193},{"period":"1month","weight":-0.1943},{"period":"3month","weight":-0.1782},{"period":"6month","weight":0.4302},{"period":"1year","weight":-0.5778},{"period":"ytd","weight":-0.0775}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0096},{"period":"3month","weight":0.02},{"period":"6month","weight":0.1744},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.117}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.010716},{"month":2,"riseRate":0.727273,"avgChangeRate":0.019923},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.03999},{"month":4,"riseRate":0.818182,"avgChangeRate":0.120087},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.017156},{"month":6,"riseRate":0.727273,"avgChangeRate":0.085503},{"month":7,"riseRate":0.583333,"avgChangeRate":0.052186},{"month":8,"riseRate":0.666667,"avgChangeRate":0.067372},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.007561},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.131245},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.033571},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.029653}],"exchange":"NYSE","name":"Evolent Health","nameEN":"Evolent Health"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evolent Health(EVH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evolent Health(EVH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evolent Health,EVH,Evolent Health股票,Evolent Health股票老虎,Evolent Health股票老虎国际,Evolent Health行情,Evolent Health股票行情,Evolent Health股价,Evolent Health股市,Evolent Health股票价格,Evolent Health股票交易,Evolent Health股票购买,Evolent Health股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evolent Health(EVH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evolent Health(EVH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction